Home / Financial Report / June 27 Market Close: GovCon Index Plunge Deepens on Post-Brexit Fallout’s Second Day

June 27 Market Close: GovCon Index Plunge Deepens on Post-Brexit Fallout’s Second Day

GovConIndexDOWNThe GovCon Index lost two full percentage points for a second consecutive trading session Monday as global financial markets continued to indicate investor concerns over the prospects of Britain’s vote Thursday to leave the European Union.

Executive Mosaic‘s GovCon Index closed down 2.004 percent to 75.777 with Vectrus (NYSE: VEC) and Northrop Grumman (NYSE: NOC) as the GCI’s only gainers at respective changes of 1.2 and 0.68 percent.

Monday’s sharp decline in the GCI and general U.S. stock market followed Friday’s steep losses in global financial markets that Standard and Poor’s estimated to total $2 trillion  as a result of investor concerns over uncertainty resulting from the U.K.’s “Brexit” vote.

Lockheed Martin (NYSE: LMT) and Leidos Holdings (NYSE: LDOS) briefly flirted with gains in midday and late afternoon trade before their regressions back into negative territory.

Raytheon (NYSE: RTN) also briefly spiked into green during the 12 p.m. Eastern time hour then held at a decline as Boeing (NYSE: BA) tumbled 3.02 percent and General Dynamics (NYSE: GD) fell 2.26 percent, while Lockheed pared its morning losses to close down 41 cents.

Market Summary

Advancing GovCon Index Issues 2
Declining GovCon Index Issues 28
Unchanged GovCon Index Issues 0
Index Value Net Change % Change
GovCon Index 75.777 -1.550 -2.004%
S&P 500 2, 000.54 -36.87 -1.81%
Dow Jones Industrial Average 17, 140.24 -260.51 -1.50%
NASDAQ 4, 594.44 -113.54 -2.41%

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.